AS Roma breathes a sigh of relief following the latest news regarding the injuries of Wesley França and Paulo Dybala. Both players are not expected to be sidelined for long periods, a crucial relief for the team as they prepare to face significant challenges in the coming weeks.
Dybala, who missed the 2-2 draw against Napoli at the Estadio Maradona, was dealing with recurring knee pain. However, according to Corriere dello Sport, the most recent issue was caused by mild inflammation in his leg, rather than a strain or tear. This good news opens up the possibility of him returning to the pitch next weekend against Cremonese in Serie A. However, the team may choose to rest him, aiming to ensure that the Argentine star is in top form for the colossal clash against Juventus on March 1.
The situation is no different for Wesley, who started as a starter against Napoli but had his match abruptly interrupted following a foul committed by Amir Rrahmani in the box. The incident resulted in a penalty, successfully converted by Donyell Malen, which put Roma ahead. Unfortunately, both Wesley and Rrahmani sustained injuries during the incident, with the full-back reporting an ankle problem.
Fortunately, medical examinations revealed that there are no fractures or breaks in Wesley’s ankle. It is an impact injury, with a strong bruise, but, like Dybala, he may also be available to play against Cremonese, or even against Juventus, should Roma decide to proceed with caution.
The situation of both players is critical, not only for the team’s immediate performance but also for the morale and confidence of the squad. With Serie A entering a decisive phase, every healthy player is vital for the fight for qualification for European competitions and for the prestige that a clash with Juventus represents. Roma, under the leadership of Gian Piero Gasperini, will need to carefully assess each player’s options, ensuring that everyone is ready for the upcoming battle.
Discover more from Apito Final
Subscribe to get the latest posts sent to your email.
